287 related articles for article (PubMed ID: 15981773)
1. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance).
Lee HY; Park HC; Seo BJ; Do JY; Yun SR; Song HY; Kim YH; Kim YL; Kim DJ; Kim YS; Ahn C; Kim MJ; Shin SK
Perit Dial Int; 2005; 25(3):248-55. PubMed ID: 15981773
[TBL] [Abstract][Full Text] [Related]
2. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome.
Lee HY; Choi HY; Park HC; Seo BJ; Do JY; Yun SR; Song HY; Kim YH; Kim YL; Kim DJ; Kim YS; Kim MJ; Shin SK
Nephrol Dial Transplant; 2006 Oct; 21(10):2893-9. PubMed ID: 16957012
[TBL] [Abstract][Full Text] [Related]
3. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
[TBL] [Abstract][Full Text] [Related]
4. First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag.
Lage C; Pischetsrieder M; Aufricht C; Jörres A; Schilling H; Passlick-Deetjen J
Perit Dial Int; 2000; 20 Suppl 5():S28-32. PubMed ID: 11229609
[TBL] [Abstract][Full Text] [Related]
5. Can biocompatible dialysis fluids improve outcomes in peritoneal dialysis patients?
Woodrow G
Perit Dial Int; 2005; 25(3):230-3. PubMed ID: 15981769
[No Abstract] [Full Text] [Related]
6. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial.
Choi HY; Kim DK; Lee TH; Moon SJ; Han SH; Lee JE; Kim BS; Park HC; Choi KH; Ha SK; Han DS; Lee HY
Perit Dial Int; 2008; 28(2):174-82. PubMed ID: 18332454
[TBL] [Abstract][Full Text] [Related]
7. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
8. Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial.
Farhat K; Douma CE; Ferrantelli E; Ter Wee PM; Beelen RHJ; van Ittersum FJ
Perit Dial Int; 2017; 37(3):273-282. PubMed ID: 28348100
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible dialysis fluids for peritoneal dialysis.
Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
[TBL] [Abstract][Full Text] [Related]
10. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats.
Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A
Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803
[TBL] [Abstract][Full Text] [Related]
11. A new neutral-pH low-GDP peritoneal dialysis fluid.
Himmele R; Jensen L; Fenn D; Ho CH; Sawin DA; Diaz-Buxo JA
Perit Dial Int; 2012; 32(4):444-52. PubMed ID: 22383632
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.
Rippe B; Simonsen O; Heimbürger O; Christensson A; Haraldsson B; Stelin G; Weiss L; Nielsen FD; Bro S; Friedberg M; Wieslander A
Kidney Int; 2001 Jan; 59(1):348-57. PubMed ID: 11135090
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial.
Howard K; Hayes A; Cho Y; Cass A; Clarke M; Johnson DW
Am J Kidney Dis; 2015 May; 65(5):773-9. PubMed ID: 25746151
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival.
Srivastava S; Hildebrand S; Fan SL
Kidney Int; 2011 Nov; 80(9):986-991. PubMed ID: 21814174
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients.
Woodrow G
Perit Dial Int; 2006; 26(1):113-4. PubMed ID: 16541510
[No Abstract] [Full Text] [Related]
16. A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients.
Brown F; Johnson DW
Perit Dial Int; 2006; 26(1):112-3; author reply 114. PubMed ID: 16538887
[No Abstract] [Full Text] [Related]
17. Glucose degradation products and peritoneal membrane function.
Witowski J; Bender TO; Gahl GM; Frei U; Jörres A
Perit Dial Int; 2001; 21(2):201-5. PubMed ID: 11330569
[TBL] [Abstract][Full Text] [Related]
18. A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.
Lai KN; Lam MF; Leung JC; Chan LY; Lam CW; Chan IH; Chan HW; Li CS; Wong SS; Ho YW; Cheuk A; Tong MK; Tang SC
Perit Dial Int; 2012; 32(3):280-91. PubMed ID: 22045098
[TBL] [Abstract][Full Text] [Related]
19. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center.
Sanchez AR; Madonia C; Rascon-Pacheco RA
Kidney Int Suppl; 2008 Apr; (108):S76-80. PubMed ID: 18379553
[TBL] [Abstract][Full Text] [Related]
20. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.
Johnson DW; Brown FG; Clarke M; Boudville N; Elias TJ; Foo MW; Jones B; Kulkarni H; Langham R; Ranganathan D; Schollum J; Suranyi M; Tan SH; Voss D;
J Am Soc Nephrol; 2012 Jun; 23(6):1097-107. PubMed ID: 22440906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
